The MD Anderson Symptom Inventory for brain tumor (MDASI-BT) is a site-specific module. Along with the core MDASI’s 13 symptom items and 6 interference items, the MDASI-BT also assesses 9 symptoms specific to brain tumors:
- weakness on one side of the body
- difficulty understanding
- difficulty speaking
- difficulty concentrating
- problems with vision
- change in appearance
- change in bowel pattern (diarrhea or constipation)
Order the MDASI Brain Tumor Module
Use our convenient online form to order the MDASI-BT for use in your clinical research, clinical practice, funded and non-funded academic research, commercial research, or reproduction in educational materials or other publications.
Every MDASI Module Contains...
All 13 MDASI core symptoms
pain, fatigue, nausea, disturbed sleep, distress, shortness of breath, difficulty remembering, lack of appetite, drowsiness, dry mouth, sadness, vomiting, numbness/tingling
All 6 MDASI interference items
general activity, mood, work, relations with others, walking, enjoyment of life
- Purpose: To assess the severity of multiple brain tumor-related symptoms and the impact of these symptoms on daily functioning
- Population: Patients with symptoms caused by brain tumor and its treatment
- Assessment areas: Severity of multiple symptoms and the impact of symptoms on daily functioning during the last 24 hours
- Method: Self-report; paper-and-pencil form or tablet PC (self-administered or via interview), or telephone-based interactive voice response (IVR) system
- Time required: Five minutes
- Scoring: Please see the MDASI User's Guide
- Reliability: Cronbach alpha reliability ranges from 0.67 to 0.91
Click on a linked language to view a sample in PDF format.
Don't see a language you need? Contact us at email@example.com.
|Psychometrically and Linguistically Validated||Linguistically Validated|
Armstrong TS, Mendoza T, Gning I, et al. Validation of the M. D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol 80(1): 27-35, 2006.
Armstrong TS, Cohen M, Eriksen L, Cleeland C. Content validity of self-report measurement instruments: an illustration from the development of the brain tumor module of the M. D. Anderson Symptom Inventory. Oncol Nurs Forum 32(3): 669-676, 2005.
Cleeland CS, Mendoza TR, Wang XS, et al. Assessing Symptom Distress in Cancer: The M. D. Anderson Symptom Inventory. Cancer 2000; 89:1634-1646.
Gning I, Armstrong TS, Wefel JS, Acquaye A, Vera-Bolanos E, Mendoza TR, Gilbert MR, Cleeland CS. Validation of the M. D. Anderson Symptom Inventory-Brain Tumor (MDASI-BT) Caregiver version. [abstract]. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Research Retreat, Houston TX, May 24, 2012.
Armstrong TS, Wefel JS, Gning I, et al. Congruence of primary brain tumor patient and caregiver symptom report. Cancer 118(20): 5026-5037, 2012.
Armstrong TS, Vera-Bolanos E, Gning I, et al. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer 117(14): 3222-3228, 2011.
Armstrong TS, Gning I, Mendoza TR, et al. Clinical utility of the MDASI-BT in patients with brain metastases. J Pain Symptom Manage 37(3): 331-340, 2009.